Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

In vivo modification of adriamycin-induced apoptosis in L-5178Y lymphoma cell-bearing mice by (+)-alpha-tocopherol and superoxide dismutase.

Bravo-Cuellar A, Gómez-Contreras PC, Lerma-Díaz JM, Hernández-Flores G, Domínguez-Rodríguez JR, Ortíz-Lazareno P, Cervantes-Munguia R, Orbach-Arbouys S.

Cancer Lett. 2005 Nov 8;229(1):59-65.

PMID:
16157219
2.

In vivo inhibition by antioxidants of adriamycin-induced apoptosis in murine peritoneal macrophages.

Dominguez-Rodriguez JR, Gomez-Contreras PC, Hernandez-Flores G, Lerma-Diaz JM, Carranco A, Cervantes-Munguia R, Orbach-Arbouys S, Bravo-Cuella A.

Anticancer Res. 2001 May-Jun;21(3B):1869-72.

PMID:
11497270
3.

In vivo adriamycin-induced apoptosis in peritoneal murine macrophages: partial participation of a caspase cascade.

Domínguez-Rodríguez JR, Chaparro-Huerta V, Hernández-Flores G, Gómez-Contreras PC, Lerma-Dáz JM, Ortiz-Lazareno PC, Cervantes-Munguia R, Orbach-Arbouys S, Scott-Algara D, Cuellar AB.

Anticancer Res. 2004 Sep-Oct;24(5A):2689-96.

4.

Adriamycin induces apoptosis in rat thymocytes.

Azmi S, Bhatia L, Khanna N, Dhawan D, Singh N.

Cancer Lett. 1997 Jan 1;111(1-2):225-31.

PMID:
9022151
5.

Enhancement of nitric oxide and superoxide generations by alpha-tocopheryl succinate and its apoptotic and anticancer effects.

Fukuzawa K, Kogure K, Morita M, Hama S, Manabe S, Tokumura A.

Biochemistry (Mosc). 2004 Jan;69(1):50-7. Review.

6.
7.

High cytotoxicity of alpha-tocopheryl hemisuccinate to cancer cells is due to failure of their antioxidative defense systems.

Kogure K, Hama S, Manabe S, Tokumura A, Fukuzawa K.

Cancer Lett. 2002 Dec 5;186(2):151-6.

PMID:
12213284
8.

Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.

Hahn T, Szabo L, Gold M, Ramanathapuram L, Hurley LH, Akporiaye ET.

Cancer Res. 2006 Oct 1;66(19):9374-8.

9.

Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.

Lin H, Hou CC, Cheng CF, Chiu TH, Hsu YH, Sue YM, Chen TH, Hou HH, Chao YC, Cheng TH, Chen CH.

Mol Pharmacol. 2007 Nov;72(5):1238-45. Epub 2007 Aug 1.

10.

Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.

Mi JX, Wang GF, Wang HB, Sun XQ, Ni XY, Zhang XW, Tang JM, Yang DJ.

Acta Pharmacol Sin. 2008 Dec;29(12):1467-77. doi: 10.1111/j.1745-7254.2008.00901.x.

11.

Protective effect of calceolarioside on adriamycin-induced cardiomyocyte toxicity.

Kim DS, Kim HR, Woo ER, Kwon DY, Kim MS, Chae SW, Chae HJ.

Eur J Pharmacol. 2006 Jul 10;541(1-2):24-32. Epub 2006 May 9.

PMID:
16780832
12.
13.

Gamma-irradiation induced apoptosis in peritoneal macrophages by oxidative stress. Implications of antioxidants in caspase mitochondrial pathway.

Hernández-Flores G, Gómez-Contreras PC, Domínguez-Rodríguez JR, Lerma-Díaz JM, Ortíz-Lazareno PC, Cervantes-Munguía R, Sahagún-Flores JE, Orbach-Arbouys S, Scott-Algara D, Bravo-Cuellar A.

Anticancer Res. 2005 Nov-Dec;25(6B):4091-100.

14.

Doxorubicin plus tumor necrosis factor alpha combination treatments in EL4-lymphoma-bearing C57BL/6 mice.

Ehrke MJ, Verstovsek S, Ujházy P, Meer JM, Eppolito C, Maccubbin DL, Mihich E.

Cancer Immunol Immunother. 1998 Feb;45(6):287-98.

PMID:
9490198
15.

Protein kinase C-ERK1/2 signal pathway switches glucose depletion-induced necrosis to apoptosis by regulating superoxide dismutases and suppressing reactive oxygen species production in A549 lung cancer cells.

Kim CH, Han SI, Lee SY, Youk HS, Moon JY, Duong HQ, Park MJ, Joo YM, Park HG, Kim YJ, Yoo MA, Lim SC, Kang HS.

J Cell Physiol. 2007 May;211(2):371-85.

PMID:
17309078
16.

Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain.

Tangpong J, Cole MP, Sultana R, Estus S, Vore M, St Clair W, Ratanachaiyavong S, St Clair DK, Butterfield DA.

J Neurochem. 2007 Jan;100(1):191-201.

17.

Quercetin alleviates myocyte toxic and sensitizes anti-leukemic effect of adriamycin.

Han Y, Yu H, Wang J, Ren Y, Su X, Shi Y.

Hematology. 2015 Jun;20(5):276-83. doi: 10.1179/1607845414Y.0000000198. Epub 2014 Sep 9.

PMID:
25201038
18.
19.

[Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes].

Chen JH, Li Y, Yao Q, Ling R, Wang L, Li KZ, Wang Z, Chen T.

Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3039-42. Chinese.

PMID:
16324402
20.

Antitumor effects of doxorubicin followed by zoledronic acid in a mouse model of breast cancer.

Ottewell PD, Mönkkönen H, Jones M, Lefley DV, Coleman RE, Holen I.

J Natl Cancer Inst. 2008 Aug 20;100(16):1167-78. doi: 10.1093/jnci/djn240. Epub 2008 Aug 11.

PMID:
18695136

Supplemental Content

Support Center